They showed that by deleting LATS1 and LATS2 (large tumor suppressor 1 and 2), tumor immunogenicity was modulated by enhancing the content of nucleic acid released in extracellular vesicles (EVs) by tumor cells. Here, LATS2 is linked to neoplasm.